-
Study aim
-
This study is performed to determine the effect of vaginal misoprostol with laminaria in comparison with vaginal misoprostol alone in termination of pregnancy of the second trimester of pregnancy (14 to 20 weeks).
-
Design
-
Clinical trial with parallel control groups, one blind, randomized, On 90 patients referring to the maternity of Ali ibn Abi Talib hospital, which are14 to 20 weeks pregnant and are a candidate for termination of pregnancy.
-
Settings and conduct
-
In the intervention group, the Laminaria will be inserted into the cervix. Then, at the same time, the misoprostol suppository contains 400 micrograms in the posterior Fornix of the vagina and examines the patient every 8 hours, and if we do not pass the fetus after 8 hours, we will repeat the vaginal misoprostol. . This process continues for up to 6 doses and, if not eliminated, until then, surgery is used to terminate the pregnancy. In the control group, misoprostol suppository 400 micrograms will be prescribed, According to the intervention group.
.
-
Participants/Inclusion and exclusion criteria
-
Entry requirements: Pregnant women between the weeks 14-20 weeks of pregnancy admitted to Imam Ali Hospital who are candidates for termination of pregnancy due to severe anomalies or fetal death. Single-swelling conditions, parietal 1 to 3, painless and uterine infections
Non-arrival conditions: Allergy to medications, taking anticoagulants and corticosteroids, having some special diseases, history of previous anesthetic on the uterus, parity of more than three, Peruvian pairs, and more.
-
Intervention groups
-
In the first group, Laminaria is inserted into the cervix. Together with 400 micrograms of vaginal progesterone every 8 hours to 6 times and another 400 micrograms of vaginal progesterone every 8 hours to 6 times.
-
Main outcome variables
-
The average need for curettage, Labor time, Hospital admission time after termination of pregnancy.